Jennison Associates’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-224,184
| Closed | -$10M | – | 652 |
|
|
2021
Q4 | $10M | Sell |
224,184
-4,238
| -2% | -$189K | 0.01% | 442 |
|
|
2021
Q3 | $11.5M | Sell |
228,422
-146,090
| -39% | -$7.37M | 0.01% | 434 |
|
|
2021
Q2 | $29.4M | Hold |
374,512
| – | – | 0.02% | 316 |
|
|
2021
Q1 | $21.4M | Sell |
374,512
-3,000
| -0.8% | -$171K | 0.02% | 347 |
|
|
2020
Q4 | $31.6M | Sell |
377,512
-6,215
| -2% | -$521K | 0.02% | 286 |
|
|
2020
Q3 | $13.7M | Sell |
383,727
-56,914
| -13% | -$2.04M | 0.01% | 345 |
|
|
2020
Q2 | $10.7M | Buy |
440,641
+1,762
| +0.4% | +$42.6K | 0.01% | 364 |
|
|
2020
Q1 | $7.69M | Buy |
+438,879
| New | +$7.69M | 0.01% | 357 |
|